These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 38048497)
1. Global Vaccine Access Demands Combating Both Inequity And Hesitancy. Hotez PJ Health Aff (Millwood); 2023 Dec; 42(12):1681-1688. PubMed ID: 38048497 [TBL] [Abstract][Full Text] [Related]
2. Global state of education-related inequality in COVID-19 vaccine coverage, structural barriers, vaccine hesitancy, and vaccine refusal: findings from the Global COVID-19 Trends and Impact Survey. Bergen N; Kirkby K; Fuertes CV; Schlotheuber A; Menning L; Mac Feely S; O'Brien K; Hosseinpoor AR Lancet Glob Health; 2023 Feb; 11(2):e207-e217. PubMed ID: 36565702 [TBL] [Abstract][Full Text] [Related]
3. Interventions to increase COVID-19 vaccine uptake: a scoping review. Andreas M; Iannizzi C; Bohndorf E; Monsef I; Piechotta V; Meerpohl JJ; Skoetz N Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015270. PubMed ID: 35920693 [TBL] [Abstract][Full Text] [Related]
4. Addressing vaccine hesitancy and resistance for COVID-19 vaccines. Peters MDJ Int J Nurs Stud; 2022 Jul; 131():104241. PubMed ID: 35489108 [TBL] [Abstract][Full Text] [Related]
5. Causes and costs of global COVID-19 vaccine inequity. Ferranna M Semin Immunopathol; 2024 Jan; 45(4-6):469-480. PubMed ID: 37870569 [TBL] [Abstract][Full Text] [Related]
6. COVID-19 Vaccine Hesitancy Associated With Vaccine Inequity Among Healthcare Workers in a Low-Income Fragile Nation. Noushad M; Nassani MZ; Al-Awar MS; Al-Saqqaf IS; Mohammed SOA; Samran A; Yaroko AA; Barakat A; Elmi OS; Alsalhani AB; Talic YF; Rastam S Front Public Health; 2022; 10():914943. PubMed ID: 35899168 [TBL] [Abstract][Full Text] [Related]
7. The impact of national income and vaccine hesitancy on country-level COVID-19 vaccine uptake. Moradpour J; Shajarizadeh A; Carter J; Chit A; Grootendorst P PLoS One; 2023; 18(11):e0293184. PubMed ID: 37917650 [TBL] [Abstract][Full Text] [Related]
8. Lack of Access to Coronavirus Disease 2019 Vaccines Could Be a Greater Threat than Vaccine Hesitancy in Low-Income and Conflict Nations: The Case of Yemen. Noushad M; Al-Awar MS; Al-Saqqaf IS; Nassani MZ; Alrubaiee GG; Rastam S Clin Infect Dis; 2022 Nov; 75(10):1827-1833. PubMed ID: 35134160 [TBL] [Abstract][Full Text] [Related]
9. Identifying H1N1 and COVID-19 vaccine hesitancy or refusal among health care providers: a scoping review. Gallant AJ; Harding A; Johnson C; Steenbeek A; Curran JA JBI Evid Synth; 2023 May; 21(5):913-951. PubMed ID: 36917102 [TBL] [Abstract][Full Text] [Related]
10. Socio-demographic factors associated with COVID-19 vaccine uptake and refusal among Ugandan women. Backhaus A Global Health; 2023 Sep; 19(1):68. PubMed ID: 37674181 [TBL] [Abstract][Full Text] [Related]
11. Determinants of COVID-19 vaccine hesitancy and uptake in sub-Saharan Africa: a scoping review. Deml MJ; Githaiga JN BMJ Open; 2022 Nov; 12(11):e066615. PubMed ID: 36400736 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions. Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I Front Public Health; 2021; 9():709127. PubMed ID: 34422750 [TBL] [Abstract][Full Text] [Related]
13. Vaccine inequity-induced COVID-19 dilemma: Time to sober up. Ba Z; Qin Y; Sang Z; Wu H; Wu X; Cheng H; Ya B; Chen F Leg Med (Tokyo); 2024 Feb; 66():102364. PubMed ID: 38104356 [TBL] [Abstract][Full Text] [Related]
14. The lived experiences of a COVID-19 immunization programme: vaccine hesitancy and vaccine refusal. Chan NN; Ong KW; Siau CS; Lee KW; Peh SC; Yacob S; Chia YC; Seow VK; Ooi PB BMC Public Health; 2022 Feb; 22(1):296. PubMed ID: 35164734 [TBL] [Abstract][Full Text] [Related]
16. Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021. Lazarus JV; Wyka K; White TM; Picchio CA; Rabin K; Ratzan SC; Parsons Leigh J; Hu J; El-Mohandes A Nat Commun; 2022 Jul; 13(1):3801. PubMed ID: 35778396 [TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics. Schwarzinger M; Watson V; Arwidson P; Alla F; Luchini S Lancet Public Health; 2021 Apr; 6(4):e210-e221. PubMed ID: 33556325 [TBL] [Abstract][Full Text] [Related]
18. A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs. Qunaibi EA; Helmy M; Basheti I; Sultan I Elife; 2021 May; 10():. PubMed ID: 34042047 [TBL] [Abstract][Full Text] [Related]
19. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward. Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908 [TBL] [Abstract][Full Text] [Related]
20. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial. Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]